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Chitosan (CHT)/poly(3-caprolactone) (PCL) blend 3D ﬁber-mesh scaffolds were studied as possible
support structures for articular cartilage tissue (ACT) repair. Micro-ﬁbers were obtained by wet-spinning
of three different polymeric solutions: 100:0 (100CHT), 75:25 (75CHT) and 50:50 (50CHT) wt.% CHT/PCL,
using a common solvent solution of 100 vol.% of formic acid. Scanning electron microscopy (SEM)
analysis showed a homogeneous surface distribution of PCL. PCL was well dispersed throughout the CHT
phase as analyzed by differential scanning calorimetry and Fourier transform infrared spectroscopy. The
ﬁbers were folded into cylindrical moulds and underwent a thermal treatment to obtain the scaffolds.
mCT analysis revealed an adequate porosity, pore size and interconnectivity for tissue engineering
applications. The PCL component led to a higher ﬁber surface roughness, decreased the scaffolds swelling
ratio and increased their compressive mechanical properties. Biological assays were performed after
culturing bovine articular chondrocytes up to 21 days. SEM analysis, live-dead and metabolic activity
assays showed that cells attached, proliferated, and were metabolically active over all scaffolds formu-
lations. Cartilaginous extracellular matrix (ECM) formation was observed in all formulations. The 75CHT
scaffolds supported the most neo-cartilage formation, as demonstrated by an increase in glycosamino-
glycan production. In contrast to 100CHT scaffolds, ECM was homogenously deposited on the 75CHT and
50CHT scaffolds. Although mechanical properties of the 50CHT scaffold were better, the 75CHT scaffold
facilitated better neo-cartilage formation.
 2010 Elsevier Ltd. All rights reserved.1. Introduction
Articular cartilage (AC) regeneration using tissue engineering
(TE) approaches has been primarily proposed due to its limited
capacity of self-repair [1,2]. This mainly derives from the lack of
a vasculature network, resulting in insufﬁcient turn-over of healthy
chondrocytes to the defective sites and low productivity of char-
acteristic proteins of the surrounding extracellular matrix (ECM)
[1,2]. Three-dimensional (3D) scaffolds are particularly important
for AC TE approaches because the chondrogenic phenotype is
maintained when chondrocytes are placed in a proper 3D envi-
ronment [2].aterials, Biodegradables and
of Excellence on Tissue Engi-
lymer Engineering, University
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All rights reserved.Cartilage-speciﬁc ECM components play an important role in
regulating expression of the chondrogenic phenotype and sup-
porting chondrogenesis [3,4]. Chitosan (CHT), a naturally derived
polysaccharide, is an excellent candidate as AC TE scaffolding
biomaterial, due to its structural similarity with various glycos-
aminoglycans (GAGs) found in cartilage [5]. It was shown to
support chondrogenic activity [5] and to allow cartilage ECM
proteins expression by chondrocytes [6,7]. However, the brittleness
in the wet state (40e50% of strain at break) of CHT scaffolds [8] is
a major drawback for application in AC TE.
Among synthetic biomaterials, poly(3-caprolactone) (PCL) is
highly appealing due to its (a) physical-chemical and mechanical
characteristics [9], (b) easy process ability related to a relatively low
melting temperature (ca. 60 C) [8], (c) non-toxic degradation
products and (d) Food and Drug Administration (FDA) approval for
biomedical applications [9]. It has been previously reported that
chondrocytes attach and proliferate on PCL ﬁlms [10] and, addi-
tionally, start to produce a cartilaginous ECM in PCL scaffolds
[11,12]. However, PCL main drawbacks as scaffolding material
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phobicity and (c) its relatively slower degradation/resorption
kinetics compared to other polyesters [13,14].
When combined, the hydrophilic nature of CHTwill enhance the
wettability and permeability, with a consequent acceleration of PCL
hydrolytic degradation. The PCL component is expected to lower
the swelling ratio and improve the wet state mechanical properties
of CHT scaffolds [15]. Moreover, the bioactivity of PCL can be
enhanced when combined with natural polymers [16], as sub-
micron phase separation of hydrophilic and hydrophobic domains
could be beneﬁcial for cell adhesion.
Different methodologies have been used to combine CHT and
PCL. Due to its simplicity and effectiveness, blending allows
tailoring the materials properties by adjusting the blend compo-
sition [17]. Moreover, polymers can co-exist with minimal chem-
ical modiﬁcation [8]. However, common solvents for CHT and PCL
are scarce. 1,1,1,3,3,3-hexa-ﬂuoro-2-propanol (HFlP) [18,19] or
acetic acid [8,20] are, by far, the most used solvents. However,
HFlP is very toxic, carcinogenic, expensive and difﬁcult to remove
[21]. Alternatively, diluted acetic acid solutions lead to phase
separation [20].
3D scaffolds of blends of CHT and PCL for TE applications have
been previously developed by freeze-drying [22] and particle-
leaching [23,24]. 3D ﬁber-mesh scaffolds started to be used in TE
applications [25,26] as they present (a) an increased surface area
for cell attachment [2], (b) improved pore architecture [2], and
(c) good mechanical stability [2]. Processing CHT/PCL blends ﬁbers
was reported for the ﬁrst time by electros pinning, ﬁrst for neural
TE applications [27], and later in bone TE applications [28].
Recently, Malheiro et al. [17] processed non-woven ﬁbers of blends
of CHT and PCL, by wet-spinning. A common solvent solution of
70:30 vol.% formic acid/acetone was used and preliminary studies
were performed on folding the ﬁbers to obtain 3D ﬁber-meshes.
Shalumon et al. [29] processed CHT/PCL blend electrospun ﬁbers
using this solvent solution.
The aim of the present work was to develop CHT/PCL blend
scaffolds, based on a previous methodology to produce CHT/PCL
ﬁbers [17]. Furthermore, the suitability of these structures as
cartilage TE supports was analyzed. Three different formulations e
100:0, 75:25 and 50:50 wt.% CHT/PCL e were used, in order to
investigate the effect of polymer composition in the physical-
chemical and biological properties of the ﬁber-meshes.
2. Materials and methods
2.1. Materials
CHT (low molecular weight, 75e85% deacetylation degree, Ref. 448869), PCL
(80 KDa, Ref. 440744), formic acid, and methanol were purchased from Sigmae
Aldrich. The solvents were used without further puriﬁcation. CHT was puriﬁed by
recrystallization before being used, as described elsewhere [17]. Brieﬂy, it was dis-
solved in 1% (wt./vol.) acetic acid solution and then ﬁltered through porous
membranes (Whatman ashes ﬁlter paper, 20e25 mm, and nylon ﬁlter sheet) into
a Buckner ﬂask under vacuum. Adjusting the pH of the solution to about 8, through
the addition of NaOH, caused ﬂocculation due to deprotonation and insolubility of
the polymer at neutral pH. The polymer was then neutralized until the pH equaled
that of distilled water, frozen at 80 C and lyophilized. Polymeric solutions with
distinct concentrations were prepared according to the concentrations presented in
Table 1.Table 1
Total polymer concentration of each ﬁber composition [47].
Formulation CHT/PCL weight ratio Total Polymer
Concentration (wt./vol. %)
100CHT 100:0 13
75CHT 75:25 17
50CHT 50:50 212.2. Methods
2.2.1. Scaffold preparation
The polymeric solutions of CHTand CHT/PCL blends were prepared by dissolving
CHT and PCL in 100 vol.% formic acid, in the proportions of 100, 75, and 50 wt.% in
CHT content (Table 1), from now referred to as 100CHT, 75CHT, and 50CHT,
respectively. The solutions were left at 30 C overnight for a complete dissolution of
both polymers. After that, the solutions were placed into a 5 mL syringe with
a capillary tip having an inner diameter of 0.8 mm. A syringe pump was used to feed
the solutions into the needle tip. A coagulation bath of methanol was used to
precipitate the solutions (0.1 mL to obtain a continuous ﬁber, in order to process one
scaffold), and no air gap was left between the tip and the referred bath during the
extrusion. The ﬁbers were left in the methanol bath overnight to complete the
solidiﬁcation process. They were neutralized with 1M NaOH solution to fully
regenerate the free amine form of the polymer chains and to avoid any CHT re-
dissolution. Afterwards, the ﬁbers were washed (at least four times) with distilled
water until the pH reached a physiological value. Subsequently, they were dehy-
drated in a series of ethanol aqueous solutions (50, 70, 90 and 99.9 vol.% ethanol),
folded in plastic cylindrical moulds and dried in an oven at different temperatures
(Ta ¼ 45, 50, 55, 60, 65 and 75 C) for either ta ¼ 1.5 h or 3 h, in a similar way as
described in [17].
2.2.2. Characterization
2.2.2.1. Scanning electron microscopy (SEM). An XL 30 ESEM-FEG Philips microscope
was used to analyze the phase structures of the ﬁbers, before and after solvent
etching, to evaluate the over all 3D structure of the constructs and for chondrocyte
proliferation and differentiation studies. Prior SEM analysis, the constructs were
ﬁxedwith formalin (only for the biological assays), dehydrated using graded ethanol
solutions and critical point dried (Balzers CPD 030). All samples were coated with
gold (Cressington Sputter Coater). The analysis was performed at an accelerating
voltage of 10 kV and magniﬁcations from 200 to 2000.
2.2.2.2. Differential scanning calorimetry (DSC). The DSC experiments were con-
ducted in a Q100 calorimeter with refrigerated cooling system (TA Instruments).
Prior the scans, the temperature and energy calibrations were performed with an
indium standard. All the samples were (a) left at 0 C for 2 min, (b) heated from 0 to
100 C, (c) left at 100 C for 2 min to erase the thermal history, (d) cooled down to
0 C, (e) left again at 0 C for 2 min, and (f) re-heated to 100 C. The heating and
cooling rate was of 10 C/min. The melting temperature (Tm) and melting enthalpy
(DHm) of PCL were determined from the ﬁrst and second heating scans. The peak
temperature (Tm) and peak area (DHm) values were calculated using the TA
Instruments Universal Analysis software. The crystallinity degree (cc) can be
calculated applying equation (1).
cc ¼ DHm=DH0uw (1)
where DHu0w is the melting enthalpy of 100% crystalline PCL (i.e. 166 J/g [17]) and w
is the weight fraction of PCL in the blend.
2.2.2.3. Fourier transform infrared (FTIR) Spectroscopic imaging measurements. A
PerkineElmer Spectrum Spotlight 200 FTIR Microscope Systemwas used to perform
the imaging measurements. The sample ﬁbers were embedded in a resin (Epoﬁx Kit,
Struers, composition as given by the company: bisphenol-A-(epichlorhydrin), epoxy
resin, oxirane and mono[(C12-14-alkyloxy)methyl] resin) for further cross-sections
observation and consequent analysis in order to study the distribution of the
polymers in the ﬁbers. The preparation of the raw PCL sample consisted in a trans-
versal cut of a PCL bead. The resinwas left to solidify overnight at room temperature
and the samples were subsequently cut intoz10 mm thick slices. The sectioning of
the resin embedded samples was performed with a Leitz 1401 microtome using
a glass knife at room temperature. Spectra were collected in continuous scan mode
in order to construct FTIR maps, with an area of 240  240 mm2 and a spectral
resolution of 16 cm1, by averaging 15 scans for each spectrum. The samples were
analyzed in transmittance. Both spectra were collected in the spectral range of
4000e720 cm1 and integrated by taking the areas under the curve between the
limits of the peaks of interest. The chosen region for CHT identiﬁcation corresponds
to C]O stretching of amide I, centered at approximately 1650 cm1 [30], and for the
PCL the carbonyl stretching absorption at about 1730 cm1 [30]. There is also
a characteristic peak of CHT that corresponds to the amine deformation vibration,
centered at 1590 cm1, but it could not be used due to overlap with an epoxy resin
characteristic peak. To represent PCL and CHT in the chemical maps, the carbonyl
stretching band was integrated between 1760 and 1710 cm1, while for CHT the
integrated intensity of the band from 1670 to 1630 cm1 was evaluated.
2.2.2.4. Micro-computed tomography (mCT). The ﬁber-mesh scaffolds were analyzed
using a high-resolution micro-computed tomography (mCT) Skyscan 1072 scanner
(Skyscan, Kontich, Belgium). The scaffolds were scanned in a high-resolution mode
using a pixel size of 8.70 mm and integration time of 1.7 ms. The X-ray source was set
at 50 keV of energy and 201 mA of current. Representative data sets of 150 slices were
transformed into a binary picture using a dynamic threshold of 60e255 (grey
values) to distinguish polymer material from pore voids. This data was used for
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the porosity and pore size. 3D virtual models of representative regions in the bulk of
the scaffolds were also created, visualized, and registered using both image pro-
cessing softwares (ANT 3-D creator v2.4, SkyScan).
2.2.2.5. Swelling tests. For the swelling studies, dried scaffolds of each formulation
were weighted (Wd) e prior immersion in phosphate-buffered saline (PBS) for 24 h,
at 37 C. After 2, 4, 6, 8 and 24 h of immersion, the samples were weighted (wet, Ws)
(n ¼ 2). The superﬁcial water was removed prior weighing with oil paper. The
swelling ratio (Q) was obtained using equation (2).
Q ¼ ðWs WdÞ=Wd (2)
2.2.2.6. Mechanical properties. The mechanical behavior of the three formulation
scaffolds inwet state was tested, under static compression solicitation. The scaffolds
were immersed in phosphate-buffered solution (PBS) at physiological pH (z7.4) and
temperature (z37 C) for 3 days for complete hydration. The unconﬁned static
compressive mechanical properties of the scaffolds were measured using an INS-
TRON 5543 (Instron Int. Ltd., U.S.A.), with a load cell of 1 kN, for 60% of strain, at
a loading rate of 2 mm/min. The initial linear modulus on the stress/strain curves
(n ¼ 3), obtained by the secant method, deﬁnes the compressive modulus (or Young
modulus).
2.2.2.7. Chondrocyte Isolation and seeding. Bovine cartilage was harvested from the
patellarefemoral groove of calf legs. Cartilage tissue was cut into small pieces and
chondrocytes were isolated by incubation in Dulbecco’s modiﬁed Eagle’s medium
(Gibco) (DMEM) containing 0.2% type II collagenase at 37 C for 8 h. The isolated
chondrocytes were washed, centrifuged and re-suspended in DMEM with 10% heat
inactivated fetal bovine serum (FBS, SigmaeAldrich), Penicillin/Streptomycin 100U/
100 mg/mL (Invitrogen), 0.1 mM MEMnonessential amino acids (Gibco), 0.2 mM
ascorbic acid 2-phosphate (Invitrogen) and 0.4 mM proline (SigmaeAldrich) and
culture expanded. At conﬂuence, the cells were detached using 0.25 wt.% trypsin in
sterile PBS, washed with PBS, re-suspended in culturemedium, and seeded (passage
2) on the scaffolds. The seeded constructs were incubated with the medium referred
above.
For chondrogenic activity assessment studies, freshly isolated chondrocytes
(passage 0) from the cartilage tissuewere immediately seeded on the scaffolds and the
constructs were cultured in chondrocyte differentiation medium composed of high
glucose DMEM with 0.1 mM dexamethasone (Sigma), 2 mM L-glutamine (Glutamax,
Gibco), 100 mg/mL sodium pyruvate (Sigma), 0.2 mM ascorbic acid 2-phosphate
(Invitrogen), 0.4mMproline (SigmaeAldrich), 50mg/mL insulinetransferrineselenite
(ITS þ Premix, BD biosciences), 100 mg/mL penicillin, 100 mg/mL streptomycin and
10 ng/mL transforming growth factor-b3 (TGF-b3, R&D Systems).
Prior cell seeding in both studies, the scaffolds were sterilized by immersion in
a solution of 70 vol.% of ethanol for 4 h, washed in PBS for 1 h (three times) and left
immersed in PBS overnight. Then, the scaffolds were incubated in the following
culture media for 2 days: proliferation medium for cell viability studies and differ-
entiation medium (serum-free) for chondrogenic activity studies. Cells in culture
ﬂasks and on scaffolds were incubated in a humidiﬁed atmosphere of 5% CO2 at
37 C. The medium was replaced every 2 or 3 days. For both proliferation and
differentiation studies, each scaffold was seeded with 5  105 cells (in 20 mL of cell
suspension).
2.2.2.8. Cell viability studies. Cell viability and metabolic activity was studied using
a Live-dead assay and MTT [3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2HO tetra-
zolium bromide] assay. At days 1, 3, 7, 14 and 21, the 3D constructs were rinsed with
sterile PBS and stained with calcein/ethidium homodimer using the Live-dead assay
Kit (Invitrogen). Sections were immediately examined with an inverted ﬂuorescence
microscope (Nikon Eclipse E400) using a FITC/Texas Red ﬁlter. Calcein AM is capable
of permeating the plasma membrane of viable cells, where it is cleaved by intra-
cellular esterases - and produces green ﬂuorescence. Ethidium-bromide homo-
dimer-1 is able to enter cells with damaged membranes and binds to fragmented
nucleic acids, thereby producing red ﬂuorescence in dead cells.
MTT staining was performed using 1% (total medium volume) of MTT solution
(5 mg/mL, Gibco) and an incubation time of 2h. Samples were visualized using
a light microscope. Dissolved MTT can be converted to an insoluble purple for-
mazan by dehydrogenase enzymes that catalyze the cleavage of the tetrazolium
ring in MTT.
2.2.2.9. Chondrogenic activity and extracellular matrix production assessment
studies. For histological analysis, samples were ﬁxed in 10% formalin for 1 h,
embedded inparafﬁn, andprocessedusing standardhistological procedures. Sections
(5 mm thick) were obtained with a microtome and used for all stainings. After rehy-
dration with xylene and an ethanol series (from 100 to 70 vol.%) the samples were
stained with safranin-O/fast green [31] and alcian blue/nuclear fast red [32]. Slides
were assembled with resinous medium for visualization using a light microscope
(NikonEclipseE400) and representative imagescapturedusingadigital camera (Sony
Corporation, Japan) and Matrix Vision Software (Matrix Vision GmbH, Germany).DNA and GAG quantiﬁcation assays were performed after 1, 14, and 21 days of
culture in differentiation medium. The constructs were taken from the chondrocyte
differentiation medium, washed in PBS and frozen at 80 C until further pro-
cessing. Afterwards, they were digested overnight at 56 C (>16 h) in a Tris-EDTA
buffered solution containing 1 mg/mL proteinase-K, 18.5 mg/mL pepstatin A, and
1 mg/mL iodoacetamide (SigmaeAldrich).
Quantiﬁcation of total DNAwas performedwith Cyquant dye kit according to the
manufacturers description (Molecular Probes, Eugene, Oregon, U.S.A.), using
a spectroﬂuorometer (Victor3, PerkineElmer, U.S.A.), at an excitation wavelength of
480 nm and an emission wavelength of 520 nm (n ¼ 3, in triplicate).
GAG amount was determined spectrophotometrically (Monochromator Micro-
plate Reader TECAN Saﬁre2, Austria) after reaction with dimethylmethylene blue
dye (DMMB, SigmaeAldrich) by measuring absorbance at 520 nm. The ﬁnal amount
was calculated using a standard of chondroitin sulphate B (SigmaeAldrich) (n¼ 3, in
triplicate).
2.2.2.10. Statistical analysis. Values on this study are reported asmean and standard
deviation. Statistical analysis was performed using the one-way ANOVA test, with
p < 0.05 considered as being statistically signiﬁcant.3. Results and discussion
3.1. Physical-chemical characterization of cht/pcl ﬁbers
100CHT, 75CHT and 50CHT ﬁbers were successfully obtained.
The approach reported by Malheiro et al. [17] was modiﬁed into
a simpler system, where the solvent solution is composed of
100 vol.% of formic acid.
Phase morphology and surface properties are important
parameters to be considered when a scaffold is being designed. The
homogeneity of the CHT/PCL polymeric blends is not only impor-
tant in terms of their internal structural and mechanical integrity,
but also in terms of PCL superﬁcial domains distribution. Therefore,
solvent etching was performed and the ﬁber surfaces were
analyzed by SEM (Fig. 1), before and after etching. In order to
remove the PCL phase of the blends, sample ﬁbers were immersed
in chloroform for 24 h, which dissolves PCL but not CHT. Before
etching, ﬁber’s topography (Fig. 1 (aec)) varied between the three
formulations with an increase in surface roughness with increasing
PCL concentration. After etching (Fig. 1 (def)), the blends kept their
dimensional stability, indicating that the CHT is the continuous
phase in the blend. This is consistent with Cruz et al. [20], who
reported the presence of a continuous CHT phase starting at
20 wt.% CHT content. Pore formationwas also observed on the ﬁber
surface after etching, thus conﬁrming PCL extracted domains, with
sizes in the micron scale. The distribution of the pores was rather
homogeneous in both blends. As expected, lower pore formation
was observed in etched 75CHT ﬁbers, when compared to 50CHT
ﬁbers. Such distribution of more hydrophobic (PCL) regions
dispersed in a more hydrophilic phase (CHT) may promote protein
adsorption and cell attachment under physiological conditions.
The miscibility of the blend components was analyzed by eval-
uating the changes in the Tm as a function of composition using DSC.
The DSC analysis was focused on the thermal properties of the PCL
phase in the blends. Thus, the temperature range chosen was from
0 C to 100 C to cover the melting and crystallization processes of
the PCL component. The trends obtained (from the ﬁrst and second
heat scans) are presented in Fig. 2(a, b). Two heating scans were
carried out, being the ﬁrst one used to infer about any effect of
processing on the development of the PCL structure. Analyzing the
graphs presented on Fig. 2 (c, d), both the Tm and cc values of PCL in
the blends did not vary signiﬁcantly from the values of pure PCL.
The information given by the DSC analysis about polymer
mixing homogeneity could offer a preliminary insight about the
interaction of both polymer phases in the blends. CHT and PCL are
thermodynamically not miscible, and although they may present
some compatibility degree, this mainly depends on the preparation
method [30]. As already pointed out by Olabarrieta et al. [33], a high
Fig. 1. SEM microphotographs of the ﬁbers surfaces, (a, b, c) before and (d, e, f) after the solvent etching procedure.
S.C. Neves et al. / Biomaterials 32 (2011) 1068e1079 1071degree of dispersion occurs between PCL and CHT phases, although
mixing is not observed at a molecular level [33]. Some authors
pointed out that the melting depression of PCL in CHT/PCL blends
(using HFlP [19] and aqueous acetic acid solution as solvents [8,34])Fig. 2. DSC (a) ﬁrst and (b) second heating scans for PCL, CHT and their blend ﬁbers; PCL anis an indication of the miscibility of PCL and CHT. Here, we did not
ﬁnd any linear relationship between the CHT content and the Tm
variation, as it did not vary signiﬁcantly, when compared to pure
PCL. This may indicate that phase separation exists between thed blend ﬁbers (c) melting temperature (Tm) and (d) crystallinity degree (cc) variations.
S.C. Neves et al. / Biomaterials 32 (2011) 1068e10791072two polymers. The PCL domains may aggregate and crystallize
without signiﬁcant interference from CHT. Such assumption is
supported by the SEM images (Fig. 1 (def)) that show the superﬁ-
cial features of the removed PCL domains. Corroborating this
assumption, no signiﬁcant variations on the cc of the blend ﬁbers
were observed when compared to pure PCL (Fig. 2 (d)).
FTIR analysis was performed in 10 mm thick sections of ﬁbers
embedded in epoxy resin to evaluate the distribution of CHT and
PCL in the ﬁber’s cross-sections. FTIR spectra and associated
chemical maps are presented in Figs. 3 and 4, respectively. Fig. 3 (a)
shows the spectra of the individual components, PCL and CHT, and
epoxy resin. There is a variety of detectable absorption bands
speciﬁc for PCL and CHT. The most obvious distinguishing features
are a C]O stretching of amide I centered at 1650 cm1 and an
amine deformation vibration centered at 1590 cm1, which is
speciﬁc for CHT, and a carbonyl stretching absorption at 1730 cm1
for PCL. Fig. 3 (b) shows the spectra of the blends. These show that
no signiﬁcant frequency shifts of the characteristic functional
groups occurred, when compared to pure polymers spectra. This
may also indicate that no molecular interactions happened
between the referred groups, corroborating previous works
conclusions about the interaction between the two polymers in
blends [17,35].
The blends chemical mapping (Fig. 4 (c, d)) showed a predomi-
nant yellowish color and the individual polymeric maps similar
intensities across the sectioned areas. Thus, although the polymers
are not miscible, the PCL domains over CHT seem to be well
dispersed at the intrinsic length scale of the technique used, having
sizes with dimensions lower than 10 mm.Fig. 3. Conventional FTIR spectra (only the 2000e800 cm1 range is shown) of (a) 100CHT
(solid line for 75CHT and dashed line for 50CHT). The shadow bands identify the regions thaThe used method permitted to disperse PCL domains
throughout CHT phase at the micron-level. Thus, homogeneous
wet-spun blend ﬁbers were obtained and, as only one common
non-aqueous solvent systemwas used, PCL precipitation during the
polymeric solutions preparation was avoided.
3.2. 3D ﬁber-mesh scaffolds characterization
To increase ﬁber adhesion after molding, the scaffolds were
thermally treated. In this study, the ﬁbers were heated at
a temperature (Ta) near the Tm of PCL during different periods of
time (ta). Fibers connectivity of each formulation was analyzed by
SEM for each combination of temperature and time (data not
shown). The optimal condition was Ta ¼ 60 C and ta ¼ 3 h. The
obtained ﬁber connectivity can be observed in Fig. 5 (aec), with
respective magniﬁcations in Fig. 5 (def). In this condition the ﬁbers
were connected and maintained the 3D mesh pore network. At
Ta < 60 C ﬁbers could be easily unfolded and no physical
connection was observed in SEM analysis. At Ta > 60 C the
superﬁcial PCL melted and was spread over the ﬁber surface. Fiber
adhesion almost exclusively depended on the pre-melting or
melting of superﬁcial PCL, which resulted in satisfactory ﬁber-mesh
stability as the constructs could be easily handled and kept their
shape even in a swollen state.
mCT analysis performed resulted in an indicative calculated
porosity and pore size (Table 2) from the selected volume of which
the reconstructed 3D images are presented on Fig. 5 (gei). The
analysis also revealed an adequate scaffold porosity range for TE
applications and a pore size in the acceptable range from 250 mm to(solid line), PCL (dashed line) and epoxy resin (dotted line) and (b) of the blend ﬁbers
t have been selected for the integration procedure used to obtain the images on Fig. 4.
Fig. 4. Chemical maps of four discrete compositions of the ﬁbers cross-sections. The different color intensities that can appear in the images may result from the cross-sections
different thicknesses. Green indicates the presence of CHT, red the presence of PCL and black corresponds to the epoxy resin. The smaller images present on the right side of the
blends chemical maps individualize the presence of the CHT and the PCL in the blends.
S.C. Neves et al. / Biomaterials 32 (2011) 1068e1079 1073500 mm as suggested by Lien et al. [31] to support chondrogenic
activity and consequent ECM production. The 3D reconstruction
showed similar internal structure between scaffold formulations
and highly interconnected pores. However, as the mCT was per-
formed to scaffolds in dry state, it should be mentioned that the
scaffold’s behavior in a physiological environment would likely
result in a different pore size due to swelling and water uptake.
The swelling behavior of the 3D ﬁber-meshes (Supplementary
Fig. S1 (a)) is an important parameter to be evaluated. The physio-
logical conditions imply a hydrated state of theﬁbers, also providing
an insight about the water afﬁnity degree that the scaffolds may
have, when comparing formulations. The 100CHT scaffolds showed
the highest swelling ratio, followed by the 75CHTand by the 50CHT
composition. The increase in PCL (hydrophobic) content in the
blends decreased the swelling when compared to 100CHT scaffolds.
This reinforces the hypothesis that PCL improves CHT mechanical
properties, as the poor mechanical properties of CHT (when
compared to the blends) mainly derives from its swollen wet state.
Compression tests were performed to evaluate the mechanical
performance of the 3D ﬁber-meshes in a wet environment,
mimicking the physiological conditions. The results for the Young
modulus are presented in Table 2 and a representative curve for the
deformation behavior of each of the three different ﬁber-mesh
scaffolds is presented on the graph of Supplementary Fig. S1 (b).
The formulation with lowest Young modulus value corresponds to
100CHT, followed by 75CHT and 50CHT. Therefore, as the quantity
of PCL increases, the scaffolds Young modulus also increases.3.3. Chondrocyte adhesion, viability and proliferation
We next examined the interaction of the chondrocytes with the
biomaterials. Live-dead assay demonstrated efﬁcient cell attach-
ment and evidence for cell proliferation (Fig. 6 and SEM analysis -
Supplementary Fig. S2). The cells were also metabolically active
(MTT assay - Supplementary Fig. S3). However, cells behaved
differently on the scaffolds. On CHT scaffolds, cells tended to
aggregate - as indicated, for example, by the green ﬂuorescent spots
on Fig. 6 (aed). In contrast, cells tended to spread more evenly on
scaffolds composed by CHT and PCL (Fig. 6 (eeh) and Supplemen-
tary Fig. S2 (eh)) and 50CHT (Fig. 6 (iel) and Supplementary
Fig. S2 (iel)). No differences were observed in metabolic activity
(Supplementary Fig. S3 (eh) and Supplementary Fig. S3 (iel),
respectively).
Water uptake ability is intrinsically related to the water afﬁnity
of the substrate. Surface tension can be affected by this factor,
which is partially responsible and directly related to the degree of
cell adhesion [36,37]. Surface energy (tension) of biomaterials
may inﬂuence which serum proteins adhere to their surface,
having a direct impact on their biological response, such as cell
adhesion [38,39]. The widely accepted mechanism by which cells
adhere to most TE scaffolds involves a two-step process: ﬁrst, ECM
proteins present in serum adsorb onto the scaffold material
surface and, second, cells adhere to these scaffold-adsorbed
proteins [40]. Both the composition and structure of this protein
layer critically determines cell responses [41]. The homogeneous
Fig. 5. SEMmicrophotographs of the (a, d) 100CHT, (b, e) 75CHT and (c, f) 50CHT ﬁber-meshes after the thermal treatment at Ta ¼ 60 C and ta ¼ 3 h. The (def) images correspond to
the magniﬁcation of the area delimited by the rectangular box on the (aec) images; representative 3D mCT images of the (g) 100CHT, (h) 75CHT and (i) 50CHT ﬁber-meshes.
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hydrophobic and hydrophilic features of both polymers.
Surface physical-chemical properties of biomaterials markedly
inﬂuence cell adhesion as they have an impact on non-receptor
mediated and receptor mediated attachment mechanisms [42].
Chondrocyte receptor mediated cell adhesion occurs via their
attachment to many ECM proteins, such as ﬁbronectin, vitronectin,
various collagen types, perlecan and cartilage oligomeric matrix
protein [43].
Chondrocyte-PCL interactions may be considered as non-
receptor mediated cell adhesion, since PCL surfaces are considered
inert for peptide conjugation [14,44]. Conversely, CHT presents
similarities with some GAGs found on cartilaginous ECM. The
combination of PCL and CHT domains in the blends may have been
the main reason for the initial spreading of the chondrocytes,
besides serum protein adhesion. Alternatively, cell distribution over
the blends may also derive from the lack of binding sites over PCL
domains and the chondrocytes consequent effort to ﬁnd other cells
or binding sites - like CHT domains. The proliferative behavioral
shift observed, when comparing 100CHT with the blend ﬁber-
meshes, is also related to the superﬁcial hydrophilic/hydrophobicTable 2
Mechanical properties of the scaffolds (standard deviation error also presented and
(*) stands for statistical signiﬁcant difference between formulations with p < 0.05)
and their estimated and exempliﬁcative porosity and pore size, obtained from the
mCT analysis to the representative selected volumes presented on Fig. 5 (gei).
Formulation Young Modulus (kPa) Porosity (%) Pore Size (mm)
100CHT 4.43 (0.29)* 75.6 330.2
75CHT 11.30 (0.78)* 64.3 265.3
50CHT 23.63 (3.36)* 83.2 384.7character of the ﬁbers surface. Proteins present in proliferative
medium may adhere differently to 100CHT and blend ﬁbers due to
a difference in surface energy. This may contribute to the difference
in cell spreading. However, cellematerial interactions are not only
governed by the hydrophilic character of material surfaces or
surface charge [45], even though moderately hydrophilic surfaces
have been found to promote better cell adhesion [41]. Other surface
properties such as roughness also inﬂuence cell behavior [31]. The
differences on surface roughness between 100CHT and 75CHT/
50CHT ﬁber-meshes may have also contributed to the dissimilar
chondrocyte behavior observed.
3.4. Cartilaginous Ecm formation
The typical differentiated chondrogenic phenotype consists of
chondrocytes that possess a rounded-like shape and that secrete
ECM proteins, speciﬁcally collagen II and aggrecan, with a diffuse
actin micro-ﬁlament network [46].
Chondrocytes morphology was monitored by analyzing the
constructs using SEM during the differentiation studies (Fig. 7).
The typical chondrogenic morphology was observed in all time-
points for all ﬁber-mesh scaffolds formulations. In the differenti-
ation studies, FBS derived protein adhesion onto the scaffolds
cannot be responsible for cell adhesion to the ﬁbers surfaces as the
differentiation culture medium is serum-free. Therefore, direct
cellebiomaterial interactions in combination with the inﬂuence of
surface roughness is likely to play a role in cell attachment.
Histological evaluation (Fig. 8, Supplementary Fig. S4) showed
that cartilaginous ECM production was present in all formulations
at for both time-points analyzed (14 and 21 days). In all conditions
examined, staining intensity increasewith culture time is indicative
Fig. 6. Live-dead assay showing chondrocytes at scaffold ﬁbers at day 1, 7, 14 and 21 of culture, in proliferation medium. Cells were stained with calcein-AM/ethidium homodimer
(dead cells stain red and living cells green) and visualized using ﬂuorescence microscopy. Cell density: 5105 cells/20 mL.
Fig. 7. SEM micrographs showing chondrocytes distribution and morphology over the scaffolds ﬁbers surface after 1, 14 and 21 days in culture, with differentiation medium. Cell
density: 5105 cells/20 mL.
S.C. Neves et al. / Biomaterials 32 (2011) 1068e1079 1075
Fig. 8. Histological cross-sections show GAGs production (stained red) on the (aed) 100CHT, (eeh) 75CHT and (iel) 50CHT scaffolds, on day 14 (a, b, e, f, i, j) and day 21 (c, d, g, h, k,
l) of culture in differentiation medium, by safranin-O staining. Cells are represented by the dark spots and bluish regions correspond to the scaffold material.
S.C. Neves et al. / Biomaterials 32 (2011) 1068e10791076for ECM production. The histological analysis also reveals round-
like cell aggregation in the 100CHT ﬁber-meshes (Fig. 8 (aed) and
Supplementary Fig. S4 (aed)), in contrast to uniformly distributed
round cells covering the scaffolds surface observed in the 75CHT
and 50CHT formulations (Fig. 8 (eel) and Supplementary Fig. S4
(el).
When chondrocytes maintain their natural spherical shape they
produce more GAGs [47]. This fact is partly corroborated by the
GAG/DNA ratio, i.e., GAG produced per cell. The DNA (Fig. 9(a)) and
GAG (Fig. 9 (b) quantiﬁcation assays, along with GAG/DNA ratio
(Fig. 9 (c))), helped to better understand the chondrocytes activity
within the scaffolds during the 21 days of culture.Fig. 9. (a) DNA and (b) GAG quantiﬁcation assays and (c) GAG/DNA ratio of the constructs
differences between different scaffold formulations on the same culture day (p < 0.05); (#)
culture days (p < 0.05).At day 1, signiﬁcant differences in cell amount (Fig. 9 (a)) were
only observed between the 100CHT and the blend formulations.
From day 1 to day 14, DNA amount increased for each scaffold
formulation. On day 14, the DNA content was only signiﬁcantly
different between the 75CHT and the 100CHT and 50CHT formu-
lations. From day 14 to day 21, the DNA amount signiﬁcantly
increased for 50CHT only, while this value remained unchanged for
the other combinations.
GAG amount (Fig. 9 (b)) increased for all scaffold formulations
over time. At day 1, GAG amount was not signiﬁcantly different
between formulations. From day 1 to day 14 (Fig. 9 (b)), there was
a signiﬁcant increase on GAG production by cells on all formulations., after 1, 14 and 21 days of culture in differentiation medium. (*) stands for signiﬁcant
represents signiﬁcant differences between the same scaffold formulation on different
S.C. Neves et al. / Biomaterials 32 (2011) 1068e1079 1077The highest production of GAG was observed for the 75CHT. From
day 14 to day 21 (Fig. 9 (b)), all formulations had an increase in GAG
amount. The highest production was again observed on 75CHT
constructs, followed by the 100CHT and 50CHT constructs present-
ing a small increase.
The graphical representation of GAG/DNA ratios (Fig. 9 (c))
shows that, for the ﬁrst day of culture, the ratios are similar
between formulations. As expected, the GAG amount per cell
amount was increased at the 14th day of culture. The highest ratio
values corresponded to the 100CHT ﬁber and 50CHT constructs.
With respect to day 21, 100CHT was the formulation with the
highest GAG/DNA ratio, followed by the 75CHT constructs and, at
last, the 50CHT.
Fig. 10 shows the over all distribution of ECM production over
the scaffolds structure. On all ﬁber-meshes formulations, matrix
quantity increased during the differentiation culture time period of
21 days. However, the distribution of the ECM throughout scaffolds
was different depending on its composition. With respect to the
100CHT constructs, ECM distribution was conﬁned to clusters at
days 14 and 21 (Fig. 10 (b, c)), respectively. On the contrary,
a homogeneous distribution of ECM was observed in the 75CHT
(Fig. 10 (e, f)) and 50CHT (Fig. 10 (h, i)) ﬁber-meshes.
From the analysis of the SEM images present on Figs. 7 and 10, it
can be observed that both 75CHT and 50CHT scaffolds resulted in
a better distribution of the cells over the scaffold when compared to
the 100CHT formulation. However, it is also known that cell
aggregation enhances cellecell signaling, resulting in a better
tissue formation [48]. Cell distribution in the scaffold is an impor-
tant parameter as it is related to ECM distribution as well. The
scaffold design also implies that cells seeded may produce ECM to
cover all the scaffold volume homogeneously. Thus, even if the
GAG/DNA ratio was higher for the 100CHT constructs, it wasFig. 10. SEM micrographs showing the 100CHT ECM distribution over the scaffolds after 1, 14observed that the ECM produced by chondrocytes over these
constructs resulted into an undesired distribution. The poor
spreading of the cells may also be related to the surface roughness,
as commented before. Consequently, blend scaffolds would lead to
a more homogeneous ECM production over the construct.
When comparing chondrocytes distribution over both blend
scaffolds, there are no main differences. This indicates that both
would lead to a homogeneous ECM dispersion over the scaffold.
This effectively occurs, as proven by the over all observation of
the constructs after the 21 days of differentiation culture (Fig. 10).
The main difference was the chondrocytes behavior during the
culturing days. On both blends, they proliferated until day 14, with
signiﬁcantly less cell number present on the 50CHT blend scaffolds.
However, a major and important behavior shift occurred from day
14 to day 21, when comparing chondrocytes seeded in 75CHT and
50CHT scaffolds. For the 75CHT constructs, cells almost stopped
proliferating and GAG production increased. On the contrary, for
the 50CHT blend scaffolds, chondrocytes continued to proliferate
and GAG production poorly increased. These results may indicate
that chondrocytes seeded over the 50CHT tended to present
ﬁbroblast-like phenotypic de-differentiation. This leads to a prolif-
erative behavior and a decrease in proteoglycan synthesis (along
with a decreased type II collagen expression and increased type I
collagen expression) [47]. The amount of CHT present in the 75CHT
blend (i.e., the amount of domains similar to cartilaginous ECM)
may also have helped chondrocytes to maintain their typical
behavior.
The ﬁber’s adhesion confers structural stability to the 3D
constructs. The scaffolds maintained their structure after the
compression tests and after cell proliferation and differentiation
studies. Blending PCL with CHT improved the mechanical proper-
ties of CHT scaffolds, as evidenced by an increase in the Youngand 21 days in culture with differentiation medium. Arrows point out ECM aggregates.
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However, the scaffoldsmechanical properties did not exactlymimic
those of AC. Besides the fact that AC has different zones, [2] which
are not mimicked in the scaffold design, there are also main
differences in the structural organization of cartilage and these
ﬁber-mesh scaffolds. In normal cartilage developmental conditions
in vivo, chondrocytes produce a very compact tissue and are
embedded in a 3D matrix [2]. To facilitate cartilage formation in
vitro, one needs to provide a 3D environment with ample possi-
bilities for cellecell contact and supply of nutrients. Our ﬁber-mesh
scaffolds are primarily designed to match these needs. Conse-
quently, the mechanical properties are not as good as those of AC,
mainly due to their porosity and CHT content. It is believed,
however, that during neo-cartilage formation the mechanical
properties will improve. Particularly the homogeneous deposition
of ECM in the CHT/PCL blends is likely to improve mechanical
properties.
The 50CHT possesses a PCL amount that was proven to be too
high (or a CHT quantity too low) that induced a loss of chondro-
genic phenotype expression, despite the best mechanical perfor-
mance. Even though the typical chondrocyte phenotype was
maintained in 100CHT scaffolds, this formulation led to cell
aggregation and consequently heterogeneous distribution of ECM.
Therefore, we believe that the PCL quantity present on 75CHT
altered CHT ﬁbers properties in a balancedway, between the 50CHT
and 100CHT formulations. Cell distribution over the 75CHT scaf-
folds was similar to that presented by the 50CHT, but the 75CHT
structure was capable of maintaining chondrocytes phenotypical
behavior in a similar way as the 100CHT. Despite the fact that
75CHT blend scaffolds showed a lower Young modulus, compared
to the 50CHT scaffolds, it is (in long-term) expected that the 75CHT
scaffold/neo-cartilage system would surpass the mechanical
properties of the 50CHT scaffold/neo-cartilage system based on
75CHT biological performance.
4. Conclusions
100CHT, 75CHT and 50CHT ﬁbers were successfully obtained by
wet-spinning using a common solvent solution of 100 vol.% formic
acid. The ﬁbers were folded into cylindrical moulds and underwent
a thermal treatment (Ta ¼ 60 C; ta ¼ 3 h) to obtain the scaffolds.
PCL domains were homogenously distributed over the blends, even
if phase separation may exist at a micrometric scale. 3D ﬁber-mesh
structures presented good integrity and stability, along with open
and interconnected porosity and pore size range suitable for TE
applications. PCL incorporation into CHT improved surface rough-
ness of the ﬁbers and diminished the swelling ratio. Blending
improved cell spreading and did not affect cell survival nor did it
impair metabolic activity. Regarding the differentiation studies, the
75CHT constructs performed the best, with the highest GAG
amount and homogeneous ECM distribution. As the PCL content
increased, the mechanical properties increased accordingly.
However, as over 50CHT chondrocytes almost stopped producing
GAG, the 75CHT formulation balanced at best the physical-chemical
and biological properties of these new CHT/PCL blend 3D ﬁber-
meshes for cartilage regeneration.
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